サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1631212

獣医腫瘍学市場の市場規模、シェア、動向分析レポート：動物タイプ別、治療法別、がんタイプ別、地域別、セグメント予測、2025年～2030年

Veterinary Oncology Market Size, Share & Trends Analysis Report By Animal Type (Canine, Feline), By Therapy (Radiotherapy, Surgery), By Cancer Type, By Region, And Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 150 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=149.35円
獣医腫瘍学市場の市場規模、シェア、動向分析レポート：動物タイプ別、治療法別、がんタイプ別、地域別、セグメント予測、2025年～2030年
出版日: 2024年12月12日
発行: Grand View Research
ページ情報: 英文 150 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

獣医腫瘍学市場の成長と動向：

世界の獣医腫瘍学の市場規模は2030年に31億1,000万米ドルに達すると予測され、2025年から2030年にかけてCAGR 12.08％で成長すると予測されます。

ペットにおけるがんの有病率の増加と動物用診断薬に対する需要が、予測期間中に市場を牽引すると予測されます。

がんの発生を推定するための犬がん登録の世界の採用は、市場成長のもう一つの促進要因です。2019年2月のfrontiers in Veterinary Scienceによると、Swiss Canine Cancer Registry（SCCR）がデータソースとして使用され、イヌとヒトのがんの将来の比較研究のために編集されました。このデータベースはさらに、ヒト集団における悪性腫瘍の発生を緩和するのに役立ち、それによって市場の成長を促進します。

獣医腫瘍学に焦点を当てた調査を行っている研究者は、獣医腫瘍学市場の成長をさらに後押ししています。例えば、2017年8月にイリノイ大学は、犬の頭頸部腫瘍の転移（体内へのがんの広がり）をより正確に検出する研究を実施しました。さらに、市場企業は新製品のイノベーションと戦略的提携にも注力しています。例えば、2018年にOasmia Pharmaceutical ABの子会社であるAdvaVetは、単一の医薬品有効成分（API）または複数のAPIを水溶性にするナノ粒子製剤ベースのXR17技術を開発しました。これは併用療法であり、ペット動物の多くのがん疾患に対する標準的な治療法でもあります。

獣医腫瘍学市場レポートハイライト

  • コンパニオンアニマルにおけるがんの有病率の増加、ペット用がん治療薬の安全性と有効性を評価するためのいくつかの臨床試験研究、および獣医がん治療における技術的進歩は、市場の成長機会を生み出すと予想されます。
  • 化学療法は、単独または他の治療法との併用でペットのがん治療に採用されることが増えているため、今後数年間で最大の収益シェアを占めました。
  • イヌのセグメントは、2024年に86.09%以上の最大の収益シェアを占め、イヌの人口が増加し、ネコと比較してイヌのがん有病率が高いです。
  • 2024年現在、北米が圧倒的なシェアを占めています。これは、有利な政府政策、企業による新製品の上市、獣医がん治療のための巨額の投資によるものです。
  • アジア太平洋は、動物の健康と支出への注目の高まり、がんに罹患するペット人口の増加、動物の安全性に対する政府の注目、ペット動物のがん症例を抑制するためのいくつかの取り組みにより、有利な成長を示すと予想されます。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 獣医腫瘍学市場の変動動向と範囲

  • 市場系統の見通し
    • 親市場
    • 補助市場
  • 市場力学
    • 市場成長要因分析
    • 市場抑制要因分析
    • 市場機会分析
    • 市場課題分析
  • 獣医腫瘍学市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析
    • 規制の枠組み
    • 主要国および主要種別の動物の推定個体数（2018～2023年）
    • 製品価格分析
    • COVID-19の影響分析

第4章 獣医腫瘍学市場：動物タイプ別の推定・動向分析

  • セグメントダッシュボード
  • 獣医腫瘍学市場：動物タイプ別の変動分析
  • 獣医腫瘍学の市場規模と動向分析、動物タイプ別（2018年～2030年）
    • イヌ
    • ネコ
    • 馬

第5章 獣医腫瘍学市場： 治療法別の推定・動向分析

  • セグメントダッシュボード
  • 獣医腫瘍学市場：治療法別の変動分析
  • 獣医腫瘍学の市場規模と動向分析：治療法別（2018年～2030年）
    • 放射線治療
    • 手術
    • 化学療法
    • 免疫療法
    • その他の治療法

第6章 獣医腫瘍学市場：がんタイプ別の推定・動向分析

  • セグメントダッシュボード
  • 獣医腫瘍学市場：がんタイプ別の変動分析
  • 獣医腫瘍学の市場規模と動向分析：がんタイプ別（2018年～2030年）
    • 皮膚がん
    • リンパ腫
    • 肉腫
    • その他

第7章 獣医腫瘍学市場： 動物タイプ、治療法、がんタイプ別の国別推定・動向分析

  • 地域ダッシュボード
  • 獣医腫瘍学市場シェア：地域別（2023年・2030年）
  • 地域展望
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • デンマーク
    • スウェーデン
    • ノルウェー
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
    • タイ
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第8章 競合情勢

  • 市場参入企業の分類
  • 市場企業の概要
  • 財務実績
  • 製品ベンチマーク
  • 市況分析、2023年（ヒートマップ分析）
  • 戦略マッピング
    • 合併と買収
    • 打ち上げ
    • パートナーシップとコラボレーション
    • 拡大
    • その他
  • 企業プロファイル
    • Elanco
    • Boehringer Ingelheim International GmbH
    • Zoetis
    • Elekta AB
    • PetCure Oncology
    • Accuray Incorporated
    • Varian Medical Systems, Inc.（parent company：Siemens Healthineers）
    • Virbac
    • Merck &Co., Inc.
    • Dechra Pharmaceuticals PLC
    • NovaVive Inc.
    • Ardent Animal Health, LLC（A BreakthrU Company）
図表

List of Tables

  • Table 1 List of secondary sources
  • Table 2 Estimated cost of dog cancer treatment (2024)
  • Table 3 North America vet oncology average price by therapy category (USD, 2024)
  • Table 4 Estimated animal population by species & by country, 2018 to 2022
  • Table 5 Veterinary oncology market estimates & forecasts, by animal type, 2018 to 2030 (USD Million)
  • Table 6 Veterinary oncology market estimates & forecasts, by therapy, 2018 to 2030 (USD Million)
  • Table 7 Global radiotherapy market, by type, 2018 - 2030 (USD Million)
  • Table 8 Global stereotactic radiation therapy market, by type, 2018 - 2030 (USD Million)
  • Table 9 Veterinary oncology market estimates and forecast, by cancer type, 2018 - 2030 (USD Million)
  • Table 10 Ongoing veterinary sarcoma clinical trials at Colorado State University
  • Table 11 North America Veterinary Oncology Market, by Country, 2018 - 2030 (USD Million)
  • Table 12 North America Veterinary Oncology Market, by Animal Type, 2018 - 2030 (USD Million)
  • Table 13 North America Veterinary Oncology Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 14 North America Veterinary Oncology Market, by Cancer Type, 2018 - 2030 (USD Million)
  • Table 15 U.S. Veterinary Oncology Market, by Animal Type, 2018 - 2030 (USD Million)
  • Table 16 U.S. Veterinary Oncology Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 17 U.S. Veterinary Oncology Market, by Cancer Type, 2018 - 2030 (USD Million)
  • Table 18 Canada Veterinary Oncology Market, by Animal Type, 2018 - 2030 (USD Million)
  • Table 19 Canada Veterinary Oncology Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 20 Canada Veterinary Oncology Market, by Cancer Type, 2018 - 2030 (USD Million)
  • Table 21 Mexico Veterinary Oncology Market, by Animal Type, 2018 - 2030 (USD Million)
  • Table 22 Mexico Veterinary Oncology Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 23 Mexico Veterinary Oncology Market, by Cancer Type, 2018 - 2030 (USD Million)
  • Table 24 Europe Veterinary Oncology Market, by Country, 2018 - 2030 (USD Million)
  • Table 25 Europe Veterinary Oncology Market, by Animal Type, 2018 - 2030 (USD Million)
  • Table 26 Europe Veterinary Oncology Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 27 Europe Veterinary Oncology Market, by Cancer Type, 2018 - 2030 (USD Million)
  • Table 28 Germany Veterinary Oncology Market, by Animal Type, 2018 - 2030 (USD Million)
  • Table 29 Germany Veterinary Oncology Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 30 Germany Veterinary Oncology Market, by Cancer Type, 2018 - 2030 (USD Million)
  • Table 31 UK Veterinary Oncology Market, by Animal Type, 2018 - 2030 (USD Million)
  • Table 32 UK Veterinary Oncology Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 33 UK Veterinary Oncology Market, by Cancer Type, 2018 - 2030 (USD Million)
  • Table 34 France Veterinary Oncology Market, by Animal Type, 2018 - 2030 (USD Million)
  • Table 35 France Veterinary Oncology Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 36 France Veterinary Oncology Market, by Cancer Type, 2018 - 2030 (USD Million)
  • Table 37 Italy Veterinary Oncology Market, by Animal Type, 2018 - 2030 (USD Million)
  • Table 38 Italy Veterinary Oncology Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 39 Italy Veterinary Oncology Market, by Cancer Type, 2018 - 2030 (USD Million)
  • Table 40 Spain Veterinary Oncology Market, by Animal Type, 2018 - 2030 (USD Million)
  • Table 41 Spain Veterinary Oncology Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 42 Spain Veterinary Oncology Market, by Cancer Type, 2018 - 2030 (USD Million)
  • Table 43 Denmark Veterinary Oncology Market, by Animal Type, 2018 - 2030 (USD Million)
  • Table 44 Denmark Veterinary Oncology Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 45 Denmark Veterinary Oncology Market, by Cancer Type, 2018 - 2030 (USD Million)
  • Table 46 Sweden Veterinary Oncology Market, by Animal Type, 2018 - 2030 (USD Million)
  • Table 47 Sweden Veterinary Oncology Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 48 Sweden Veterinary Oncology Market, by Cancer Type, 2018 - 2030 (USD Million)
  • Table 49 Norway Veterinary Oncology Market, by Animal Type, 2018 - 2030 (USD Million)
  • Table 50 Norway Veterinary Oncology Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 51 Norway Veterinary Oncology Market, by Cancer Type, 2018 - 2030 (USD Million)
  • Table 52 Asia Pacific Veterinary Oncology Market, by Country, 2018 - 2030 (USD Million)
  • Table 53 Asia Pacific Veterinary Oncology Market, by Animal Type, 2018 - 2030 (USD Million)
  • Table 54 Asia Pacific Veterinary Oncology Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 55 Asia Pacific Veterinary Oncology Market, by Cancer Type, 2018 - 2030 (USD Million)
  • Table 56 China Veterinary Oncology Market, by Animal Type, 2018 - 2030 (USD Million)
  • Table 57 China Veterinary Oncology Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 58 China Veterinary Oncology Market, by Cancer Type, 2018 - 2030 (USD Million)
  • Table 59 Japan Veterinary Oncology Market, by Animal Type, 2018 - 2030 (USD Million)
  • Table 60 Japan Veterinary Oncology Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 61 Japan Veterinary Oncology Market, by Cancer Type, 2018 - 2030 (USD Million)
  • Table 62 India Veterinary Oncology Market, by Animal Type, 2018 - 2030 (USD Million)
  • Table 63 India Veterinary Oncology Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 64 India Veterinary Oncology Market, by Cancer Type, 2018 - 2030 (USD Million)
  • Table 65 South Korea Veterinary Oncology Market, by Animal Type, 2018 - 2030 (USD Million)
  • Table 66 South Korea Veterinary Oncology Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 67 South Korea Veterinary Oncology Market, by Cancer Type, 2018 - 2030 (USD Million)
  • Table 68 Australia Veterinary Oncology Market, by Animal Type, 2018 - 2030 (USD Million)
  • Table 69 Australia Veterinary Oncology Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 70 Australia Veterinary Oncology Market, by Cancer Type, 2018 - 2030 (USD Million)
  • Table 71 Thailand Veterinary Oncology Market, by Animal Type, 2018 - 2030 (USD Million)
  • Table 72 Thailand Veterinary Oncology Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 73 Thailand Veterinary Oncology Market, by Cancer Type, 2018 - 2030 (USD Million)
  • Table 74 Latin America Veterinary Oncology Market, by Country, 2018 - 2030 (USD Million)
  • Table 75 Latin America Veterinary Oncology Market, by Animal Type, 2018 - 2030 (USD Million)
  • Table 76 Latin America Veterinary Oncology Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 77 Latin America Veterinary Oncology Market, by Cancer Type, 2018 - 2030 (USD Million)
  • Table 78 Brazil Veterinary Oncology Market, by Animal Type, 2018 - 2030 (USD Million)
  • Table 79 Brazil Veterinary Oncology Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 80 Brazil Veterinary Oncology Market, by Cancer Type, 2018 - 2030 (USD Million)
  • Table 81 Argentina Veterinary Oncology Market, by Animal Type, 2018 - 2030 (USD Million)
  • Table 82 Argentina Veterinary Oncology Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 83 Argentina Veterinary Oncology Market, by Cancer Type, 2018 - 2030 (USD Million)
  • Table 84 Middle East & Africa Veterinary Oncology Market, by Country, 2018 - 2030 (USD Million)
  • Table 85 Middle East & Africa Veterinary Oncology Market, by Animal Type, 2018 - 2030 (USD Million)
  • Table 86 Middle East & Africa Veterinary Oncology Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 87 Middle East & Africa Veterinary Oncology Market, by Cancer Type, 2018 - 2030 (USD Million)
  • Table 88 South Africa Veterinary Oncology Market, by Animal Type, 2018 - 2030 (USD Million)
  • Table 89 South Africa Veterinary Oncology Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 90 South Africa Veterinary Oncology Market, by Cancer Type, 2018 - 2030 (USD Million)
  • Table 91 South Africa Veterinary Oncology Market, by End Use, 2018 - 2030 (USD Million)
  • Table 92 Saudi Arabia Veterinary Oncology Market, by Animal Type, 2018 - 2030 (USD Million)
  • Table 93 Saudi Arabia Veterinary Oncology Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 94 Saudi Arabia Veterinary Oncology Market, by Cancer Type, 2018 - 2030 (USD Million)
  • Table 95 UAE Veterinary Oncology Market, by Animal Type, 2018 - 2030 (USD Million)
  • Table 96 UAE Veterinary Oncology Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 97 UAE Veterinary Oncology Market, by Cancer Type, 2018 - 2030 (USD Million)
  • Table 98 Kuwait Veterinary Oncology Market, by Animal Type, 2018 - 2030 (USD Million)
  • Table 99 Kuwait Veterinary Oncology Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 100 Kuwait Veterinary Oncology Market, by Cancer Type, 2018 - 2030 (USD Million)
  • Table 101 Participants overview
  • Table 102 Financial performance
  • Table 103 Key market players pursuing approvals & clearances
  • Table 104 Key market players initiate mergers & acquisitions.
  • Table 105 Key market players initiate collaboration & partnerships.
  • Table 106 Key market players initiating product/ service launches/expansions
  • Table 107 Key market players undertaking R&D partnerships
  • Table 108 Key market players undertaking other activities.
  • Table 109 List of other key market players

List of Figures

  • Fig. 1 Veterinary oncology market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Data analysis models
  • Fig. 6 Market formulation and validation
  • Fig. 7 Data validation & publishing
  • Fig. 8 Volume x Price Analysis
  • Fig. 9 General methodology for commodity flow analysis of animal health market
  • Fig. 10 Commodity flow analysis
  • Fig. 11 Market snapshot
  • Fig. 12 Segment snapshot
  • Fig. 13 Segment snapshot
  • Fig. 14 Competitive landscape snapshot
  • Fig. 15 Veterinary oncology market value, 2024 (USD Billion)
  • Fig. 16 Ancillary market outlook, 2024
  • Fig. 17 Veterinary oncology market dynamics
  • Fig. 18 Basic annual expenses for dog and cat owners in USD (2024)
  • Fig. 19 veterinary oncology market: PORTER's analysis
  • Fig. 20 veterinary oncology market: PESTEL analysis
  • Fig. 21 Estimated number of veterinary service establishments in the U.S., 2018 to 2030
  • Fig. 22 Veterinary oncology market by animal type: key takeaways
  • Fig. 23 Veterinary oncology market by animal type, Market share, 2023 & 2030
  • Fig. 24 Canine market, 2018 - 2030 (USD Million)
  • Fig. 25 Feline market, 2018 - 2030 (USD Million)
  • Fig. 26 Equine market, 2018 - 2030 (USD Million)
  • Fig. 27 Veterinary oncology market by therapy: key takeaways
  • Fig. 28 Veterinary oncology market by therapy, market share, 2024 & 2030
  • Fig. 29 Radiotherapy market, 2018 - 2030 (USD Million)
  • Fig. 30 Stereotactic radiation therapy market, 2018 - 2030 (USD Million)
  • Fig. 31 LINAC market, 2018 - 2030 (USD Million)
  • Fig. 32 Others market, 2018 - 2030 (USD Million)
  • Fig. 33 Conventional radiation therapy market, 2018 - 2030 (USD Million)
  • Fig. 34 Surgery market, 2018 - 2030 (USD Million)
  • Fig. 35 Chemotherapy market, 2018 - 2030 (USD Million)
  • Fig. 36 Immunotherapy market, 2018 - 2030 (USD Million)
  • Fig. 37 Other therapies market, 2018 - 2030 (USD Million)
  • Fig. 38 Veterinary oncology market by cancer type: Key takeaways
  • Fig. 39 Veterinary oncology market by cancer type, market share, 2024 & 2030
  • Fig. 40 Skin Cancers market, 2018 - 2030 (USD Million)
  • Fig. 41 Lymphomas market, 2018 - 2030 (USD Million)
  • Fig. 42 Sarcomas market, 2018 - 2030 (USD Million)
  • Fig. 43 Others market, 2018 - 2030 (USD Million)
  • Fig. 44 Veterinary oncology market revenue, by region, 2023 & 2030 (USD Million)
  • Fig. 45 Regional market share analysis, 2023 & 2030
  • Fig. 46 Regional marketplace: key takeaways
  • Fig. 47 Regional marketplace: key takeaways
  • Fig. 48 Regional marketplace: key takeaways
  • Fig. 49 North America veterinary oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Key country dynamics
  • Fig. 51 U.S. veterinary oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Key country dynamics
  • Fig. 53 Canada veterinary oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Key country dynamics
  • Fig. 55 Mexico veterinary oncology market, 2018 - 2030 (USD Million)
  • Fig. 56 Europe veterinary oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Key country dynamics
  • Fig. 58 UK. veterinary oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Key country dynamics
  • Fig. 60 Germany veterinary oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Key country dynamics
  • Fig. 62 France veterinary oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Key country dynamics
  • Fig. 64 Italy veterinary oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Key country dynamics
  • Fig. 66 Spain veterinary oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Sweden veterinary oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Key country dynamics
  • Fig. 69 Denmark veterinary oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Norway veterinary oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Rest of Europe veterinary oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 Asia Pacific veterinary oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 Key country dynamics
  • Fig. 74 Japan veterinary oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 75 Key country dynamics
  • Fig. 76 China veterinary oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 77 Key country dynamics
  • Fig. 78 India veterinary oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 79 Key country dynamics
  • Fig. 80 South Korea veterinary oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 81 Key country dynamics
  • Fig. 82 Australia veterinary oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 83 Key country dynamics
  • Fig. 84 Thailand veterinary oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 85 Rest of Asia Pacific veterinary oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 86 Latin America veterinary oncology market, 2018 - 2030 (USD Million)
  • Fig. 87 Key country dynamics
  • Fig. 88 Brazil veterinary oncology market, 2018 - 2030 (USD Million)
  • Fig. 89 Argentina veterinary oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 90 Rest of Latin America veterinary oncology market, 2018 - 2030 (USD Million)
  • Fig. 91 MEA veterinary oncology market, 2018 - 2030 (USD Million)
  • Fig. 92 Key country dynamics
  • Fig. 93 South Africa veterinary oncology market, 2018 - 2030 (USD Million)
  • Fig. 94 Saudi Arabia veterinary oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 95 UAE veterinary oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 96 Kuwait veterinary oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 97 Rest of MEA veterinary oncology market, 2018 - 2030 (USD Million)
  • Fig. 98 Market participant categorization
  • Fig. 99 Heat map analysis
  • Fig. 100 Key strategies deployed by market players
目次
Product Code: GVR-4-68038-182-5

Veterinary Oncology Market Growth & Trends:

The global veterinary oncology market size is expected to reach USD 3.11 billion in 2030 and is projected to grow at a CAGR of 12.08% from 2025 to 2030. Increasing prevalence of cancer in pets and demand for veterinary diagnostics are projected to drive the market over the forecast period.

Adoption of canine cancer registry globally to estimate cancer incidences is another driving factor for the market growth. According to frontiers in Veterinary Science in February 2019, the Swiss Canine Cancer Registry (SCCR) was used as a data source and was compiled for future comparative studies of canine and human cancers. This database is further helpful in mitigating the incidence of malignant tumors in the human population, thereby driving the market growth.

Researchers carrying out studies focused on veterinary oncology are further boosting the veterinary oncology market growth. For instance, University of Illinois in August 2017, carried out study that involves more precise detection of metastasis (spread of cancer through the body) for head and neck tumors in dogs. Moreover, the market players are also focusing on new product innovation and strategic collaborations. For instance, in 2018 AdvaVet, a subsidiary of Oasmia Pharmaceutical AB, developed XR17 technology, which is nanoparticle formulation based that makes a single Active Pharmaceutical Ingredient (API) or multiple APIs water soluble. It is a combination therapy and is also a standard treatment for a number of cancer diseases in pet animals.

Veterinary Oncology Market Report Highlights:

  • Increasing prevalence of cancer in companion animals, several clinical trial studies to evaluate the safety and effectiveness of cancer therapeutics for pets and technological advancements in veterinary oncology treatment are anticipated to create growth opportunities in the market.
  • Chemotherapy accounted for the largest revenue share over the coming years, owing to its increasing adoption for pet cancer treatment either alone or in combination with other therapies.
  • The canine segment held the largest revenue share of over 86.09% in 2024, increasing the population of dogs and high prevalence of cancer in dogs as compared to cats.
  • North America held the dominant share as of 2024, due to the favorable government policies, new product launch by the companies, and huge investment for veterinary oncology treatment.
  • Asia Pacific is anticipated to witness lucrative growth due to increasing focus on animal health and expenditure, increasing number of pet population being exposed to cancer, government focus on animal safety, and several initiatives to curb cancer cases in pet animals.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased Database
    • 1.3.2. GVR's Internal Database
    • 1.3.3. Secondary Sources
    • 1.3.4. Primary Research
  • 1.4. Information/Data Analysis
  • 1.5. Market Formulation & Visualization
  • 1.6. Data Validation & Publishing
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis
    • 1.7.2. Global Market: CAGR Calculation
  • 1.8. List of Secondary Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Veterinary Oncology Market Variable Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market
    • 3.1.2. Ancillary Market
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing prevalence of cancer in pets
      • 3.2.1.2. Increasing R&D in pet cancer therapy
      • 3.2.1.3. Growing focus on animal safety
      • 3.2.1.4. Growing uptake of pet insurance
      • 3.2.1.5. Technological advancements in pet cancer treatment
      • 3.2.1.6. Increase in pet population
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High cost of treatment
      • 3.2.2.2. Adverse effects associated with therapies
      • 3.2.2.3. Limited clinical evidence
    • 3.2.3. Market Opportunity Analysis
    • 3.2.4. Market Challenge Analysis
  • 3.3. Veterinary Oncology Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitution
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political & Legal Landscape
      • 3.3.2.2. Economic and Social Landscape
      • 3.3.2.3. Technological landscape
      • 3.3.2.4. Environmental Landscape
    • 3.3.3. Regulatory Framework
    • 3.3.4. Estimated Animal Population, by Key Countries and Key Species, 2018-2023
    • 3.3.5. Product Pricing Analysis
    • 3.3.6. COVID-19 Impact Analysis

Chapter 4. Veterinary Oncology Market: Animal Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Veterinary Oncology Market Product Movement Analysis
  • 4.3. Veterinary Oncology Market Size & Trend Analysis, By Animal Type, 2018 - 2030 (USD Million)
    • 4.3.1. Canine
      • 4.3.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.3.2. Feline
      • 4.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.3.3. Equine
      • 4.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Veterinary Oncology Market: Therapy Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Veterinary Oncology Market Application Movement Analysis
  • 5.3. Veterinary Oncology Market Size & Trend Analysis, By Therapy, 2018 - 2030 (USD Million)
    • 5.3.1. Radiotherapy
      • 5.3.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 5.3.1.2. Stereotactic Radiation Therapy
        • 5.3.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
        • 5.3.1.2.2. LINAC
          • 5.3.1.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
        • 5.3.1.2.3. Other Types
          • 5.3.1.2.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 5.3.1.3. Conventional Radiation Therapy
        • 5.3.1.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.3.2. Surgery
      • 5.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.3.3. Chemotherapy
      • 5.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.3.4. Immunotherapy
      • 5.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.3.5. Other Therapies
      • 5.3.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Veterinary Oncology Market: Cancer Type Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Veterinary Oncology Market Animal Movement Analysis
  • 6.3. Veterinary Oncology Market Size & Trend Analysis, By Cancer Type, 2018 - 2030 (USD Million)
    • 6.3.1. Skin Cancers
      • 6.3.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.3.2. Lymphomas
      • 6.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.3.3. Sarcomas
      • 6.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.3.4. Others
      • 6.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Veterinary Oncology Market: Country Estimates & Trend Analysis, by animal type, therapy, & cancer type

  • 7.1. Regional Dashboard
  • 7.2. Veterinary Oncology Market Share, By Region, 2023 & 2030, USD Million
  • 7.3. Regional Outlook
  • 7.4. North America
    • 7.4.1. North America Veterinary Oncology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competition Insights
      • 7.4.2.3. U.S. Veterinary Oncology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competition Insights
      • 7.4.3.3. Canada Veterinary Oncology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competition Insights
      • 7.4.4.3. Mexico Veterinary Oncology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. Europe Veterinary Oncology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competition Insights
      • 7.5.2.3. UK Veterinary Oncology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competition Insights
      • 7.5.3.3. Germany Veterinary Oncology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competition Insights
      • 7.5.4.3. France Veterinary Oncology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Competition Insights
      • 7.5.5.3. Italy Veterinary Oncology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Competition Insights
      • 7.5.6.3. Spain Veterinary Oncology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.7. Denmark
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Competition Insights
      • 7.5.7.3. Denmark Veterinary Oncology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.8. Sweden
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Competition Insights
      • 7.5.8.3. Sweden Veterinary Oncology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.9. Norway
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Competition Insights
      • 7.5.9.3. Norway Veterinary Oncology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific Veterinary Oncology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competition Insights
      • 7.6.2.3. Japan Veterinary Oncology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competition Insights
      • 7.6.3.3. China Veterinary Oncology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competition Insights
      • 7.6.4.3. India Veterinary Oncology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. Australia
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Competition Insights
      • 7.6.5.3. Australia Veterinary Oncology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.6. South Korea
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Competition Insights
      • 7.6.6.3. South Korea Veterinary Oncology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Competition Insights
      • 7.6.7.3. Thailand Veterinary Oncology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America Veterinary Oncology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competition Insights
      • 7.7.2.3. Brazil Veterinary Oncology Market Estimates And Forecasts, 2018 - 2030
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competition Insights
      • 7.7.3.3. Argentina Veterinary Oncology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.8. Middle East & Africa
    • 7.8.1. Middle East & Africa Veterinary Oncology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Competition Insights
      • 7.8.2.3. South Africa Veterinary Oncology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Competition Insights
      • 7.8.3.3. Saudi Arabia Veterinary Oncology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Competition Insights
      • 7.8.4.3. UAE Veterinary Oncology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Competition Insights
      • 7.8.5.3. Kuwait Veterinary Oncology Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Market Participant Categorization
  • 8.2. Participants Overview
  • 8.3. Financial Performance
  • 8.4. Product Benchmarking
  • 8.5. Market Position Analysis, 2023 (Heat Map Analysis)
  • 8.6. Strategy Mapping
    • 8.6.1. MERGERS AND ACQUISITIONS
    • 8.6.2. LAUNCH
    • 8.6.3. PARTNERSHIPS & COLLABORATIONS
    • 8.6.4. EXPANSION
    • 8.6.5. OTHERS
  • 8.7. Company Profiles
    • 8.7.1. Elanco
      • 8.7.1.1. Participant's overview
      • 8.7.1.2. Financial performance
      • 8.7.1.3. Product Benchmarking
      • 8.7.1.4. Strategic initiatives
    • 8.7.2. Boehringer Ingelheim International GmbH
      • 8.7.2.1. Participant's overview
      • 8.7.2.2. Financial performance
      • 8.7.2.3. Product Benchmarking
      • 8.7.2.4. Strategic initiatives
    • 8.7.3. Zoetis
      • 8.7.3.1. Participant's overview
      • 8.7.3.2. Financial performance
      • 8.7.3.3. Product Benchmarking
      • 8.7.3.4. Strategic initiatives
    • 8.7.4. Elekta AB
      • 8.7.4.1. Participant's overview
      • 8.7.4.2. Financial performance
      • 8.7.4.3. Product Benchmarking
      • 8.7.4.4. Strategic initiatives
    • 8.7.5. PetCure Oncology
      • 8.7.5.1. Participant's overview
      • 8.7.5.2. Financial performance
      • 8.7.5.3. Product Benchmarking
      • 8.7.5.4. Strategic initiatives
    • 8.7.6. Accuray Incorporated
      • 8.7.6.1. Participant's overview
      • 8.7.6.2. Financial performance
      • 8.7.6.3. Product Benchmarking
      • 8.7.6.4. Strategic initiatives
    • 8.7.7. Varian Medical Systems, Inc. (parent company: Siemens Healthineers)
      • 8.7.7.1. Participant's overview
      • 8.7.7.2. Financial performance
      • 8.7.7.3. Product Benchmarking
      • 8.7.7.4. Strategic initiatives
    • 8.7.8. Virbac
      • 8.7.8.1. Participant's overview
      • 8.7.8.2. Financial performance
      • 8.7.8.3. Product Benchmarking
      • 8.7.8.4. Strategic initiatives
    • 8.7.9. Merck & Co., Inc.
      • 8.7.9.1. Participant's overview
      • 8.7.9.2. Financial performance
      • 8.7.9.3. Product Benchmarking
      • 8.7.9.4. Strategic initiatives
    • 8.7.10. Dechra Pharmaceuticals PLC
      • 8.7.10.1. Participant's overview
      • 8.7.10.2. Financial performance
      • 8.7.10.3. Product Benchmarking
      • 8.7.10.4. Strategic initiatives
    • 8.7.11. NovaVive Inc.
      • 8.7.11.1. Participant's overview
      • 8.7.11.2. Financial performance
      • 8.7.11.3. Product Benchmarking
      • 8.7.11.4. Strategic initiatives
    • 8.7.12. Ardent Animal Health, LLC (A BreakthrU Company)
      • 8.7.12.1. Participant's overview
      • 8.7.12.2. Financial performance
      • 8.7.12.3. Product Benchmarking
      • 8.7.12.4. Strategic initiatives